KR20030076448A - 항-ｒａｎｋ 단클론 항체 및 이를 함유한 약학 조성물 - Google Patents

항-ｒａｎｋ 단클론 항체 및 이를 함유한 약학 조성물 Download PDF

Info

Publication number
KR20030076448A
KR20030076448A KR1020030017909A KR20030017909A KR20030076448A KR 20030076448 A KR20030076448 A KR 20030076448A KR 1020030017909 A KR1020030017909 A KR 1020030017909A KR 20030017909 A KR20030017909 A KR 20030017909A KR 20030076448 A KR20030076448 A KR 20030076448A
Authority
KR
South Korea
Prior art keywords
rank
cells
monoclonal antibodies
osteoclast differentiation
antibody
Prior art date
Application number
KR1020030017909A
Other languages
English (en)
Korean (ko)
Inventor
이장희
김홍희
Original Assignee
주식회사 코메드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 코메드 filed Critical 주식회사 코메드
Publication of KR20030076448A publication Critical patent/KR20030076448A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
KR1020030017909A 2002-03-21 2003-03-21 항-ｒａｎｋ 단클론 항체 및 이를 함유한 약학 조성물 KR20030076448A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20020015461 2002-03-21
KR1020020015461 2002-03-21

Publications (1)

Publication Number Publication Date
KR20030076448A true KR20030076448A (ko) 2003-09-26

Family

ID=28450048

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020030017909A KR20030076448A (ko) 2002-03-21 2003-03-21 항-ｒａｎｋ 단클론 항체 및 이를 함유한 약학 조성물

Country Status (3)

Country Link
KR (1) KR20030076448A (fr)
AU (1) AU2003210054A1 (fr)
WO (1) WO2003080671A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100911852B1 (ko) * 2007-11-26 2009-08-11 고려대학교 산학협력단 유세포 분석기를 이용한 신규한 ｒａｎｋ와 ｒａｎｋ리간드의 결합 분석방법
KR20150063859A (ko) 2013-12-02 2015-06-10 충북대학교 산학협력단 적 백혈병 세포에서 발현되는 icama4를 인지하는 항체 및 이의 용도

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE386748T1 (de) * 2003-12-19 2008-03-15 Charite Universitaetsmedizin Verwendung von liganden von cd52 antigen zur behandlung von soliden tumoren und von knochenkrebserkrankungen
CA2560742A1 (fr) 2004-03-23 2005-10-06 Biogen Idec Ma Inc. Agents de couplage recepteurs et leurs applications therapeutiques
DK1994155T4 (da) 2006-02-13 2022-07-25 Daiichi Sankyo Co Ltd Polynukleotid- og polypeptidsekvenser involveret i fremgangsmåden med knogleremodellering
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
WO2013067639A1 (fr) 2011-11-07 2013-05-16 UNIVERSITé LAVAL Utilisation d'antagonistes de rank/rankl pour le traitement de troubles neuromusculaires, de myopathies génétiques et/ou de myopathies non génétiques et/ou pour la régulation de l'inactivité, des maladies et du vieillissement du muscle squelettique et cardiaque
KR20150036274A (ko) 2012-07-19 2015-04-07 알레시아 바이오쎄라퓨틱스 인코포레이티드 항-siglec-15 항체
US20220227876A1 (en) * 2018-12-05 2022-07-21 The Council Of The Queensland Institute Of Medical Research Rank antagonists and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2274987C (fr) * 1996-12-23 2012-01-24 Immunex Corporation Ligand pour l'activateur des recepteurs du nf-kappa b, ligand membre de la superfamille de tnf

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100911852B1 (ko) * 2007-11-26 2009-08-11 고려대학교 산학협력단 유세포 분석기를 이용한 신규한 ｒａｎｋ와 ｒａｎｋ리간드의 결합 분석방법
KR20150063859A (ko) 2013-12-02 2015-06-10 충북대학교 산학협력단 적 백혈병 세포에서 발현되는 icama4를 인지하는 항체 및 이의 용도

Also Published As

Publication number Publication date
AU2003210054A1 (en) 2003-10-08
WO2003080671A1 (fr) 2003-10-02

Similar Documents

Publication Publication Date Title
KR100895749B1 (ko) Ｎｋｇ２ｄ의 조절
EP2890715B1 (fr) Anticorps de liaison double à agent unique anti-pd-l1 et pd-l2 et procédés d'utilisation
WO1997027873A1 (fr) Anticorps destines a moduler la transmigration des neutrophiles induite par cd47
JP2004041195A (ja) 新規蛋白質及びその製造方法
KR20080059449A (ko) 치료용 약제
CN110914304A (zh) Cd96抗体、其抗原结合片段及医药用途
CN114206929B (zh) 一种抗tigit免疫抑制剂及应用
KR20030076448A (ko) 항-ｒａｎｋ 단클론 항체 및 이를 함유한 약학 조성물
AU2013269652B2 (en) TLR3 binding agents
WO2008099185A1 (fr) Anticorps monoclonaux humains dirigés contre le récepteur de la thyrotropine agissant en tant qu'antagonistes
JP3800175B2 (ja) 新規なアグリカナーゼ
EP0503646A1 (fr) Anticorps monocloneaux dressés contre l'antigène-3 associé à la fonction lymphocyte
KR20070042994A (ko) 항시노비올린 항체
KR20100093451A (ko) Ｓｃｙｅ1을 인지하는 단클론 항체 및 이의 용도
TWI826934B (zh) 新穎抗ｐａｄ４抗體
KR20230108156A (ko) Cd40l에 특이적으로 결합하는 항체 및 그의 용도
JP2024028198A (ja) 新規抗ｐａｄ４抗体を含む医薬組成物
KR20110095541A (ko) 무등 단백질에 대한 단일클론 항체 및 그 응용
WO2002062990A1 (fr) Anticorps et utilisation de cet anticorps
WO2001023428A2 (fr) Polypeptides associes au recepteur de l'interleukine-2

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application